Balloon Dilatation of the Prostate

  • J. A. Vale
  • R. S. Kirby
Conference paper

Abstract

Benign prostatic hyperplasia (BPH) is a major cause of morbidity amongst elderly men and is reported to have an incidence of 88% amongst men in their 90s [3]. With advances in other fields of medicine and increasing longevity, the number of patients requiring treatment for this complaint will inevitably increase. Already it is estimated that a 50-year-old man has a 20%–25% chance of requiring a prostatectomy during his lifetime [4], and more than 300 000 prostatectomies are performed in the United States annually. This represents an enormous financial burden to health services and private insurance companies.

Keywords

Placebo Catheter Microwave Shrinkage Tate 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Aalkjaer V (1965) Transurethral resection/prostatectomy versus dilatation treatment in hypertrophy of the prostate: II. A comparison of the late results. Urol Int 20:17–22CrossRefGoogle Scholar
  2. 2.
    Baert L, Werbrouck P, Bamelis B et al. (1991) Balloon dilatation of the prostate. Urol Int 47:74–76PubMedCrossRefGoogle Scholar
  3. 3.
    Berry SJ, Coffey DS, Walsh PC et al. (1984) The development of human benign prostatic hyperplasia with age. J Urol 132:474–479PubMedGoogle Scholar
  4. 4.
    Birkhoff JJ (1983) Natural history of benign prostatic hypertrophy. In: Hinman F (ed) Benign prostatic hypertrophy. Springer, Berlin Heidelberg New YorkGoogle Scholar
  5. 5.
    Bruskewitz RC, Larsen EH, Madsen P et al. (1986) 3-Year follow-up of urinary symptoms after transurethral resection of the prostate. J Urol 136:613–615PubMedGoogle Scholar
  6. 6.
    Burhenne HJ, Chisholm RJ, Quenville NF (1984) Prostatic hyperplasia: radiological intervention. Radiology 152:655–657PubMedGoogle Scholar
  7. 7.
    Castaneda F, Lund G, Larson BW et al. (1987) Prostatic urethra: experimental dilation in dogs. Radiology 163:645–648PubMedGoogle Scholar
  8. 8.
    Chappie CR, Milroy EJG, Rickards D (1990) Permanently implanted urethral stent for prostatic obstruction in the unfit patient. Br J Urol 66:58CrossRefGoogle Scholar
  9. 9.
    Daughtry JD, Rodan BA, Bean WJ (1990) Balloon dilatation of prostatic urethra. Urology 36:203–209PubMedCrossRefGoogle Scholar
  10. 10.
    Deisting W (1956) Transurethral dilatation of the prostate: a new method in the treatment of prostatic hypertrophy. Urol Int 2:158–171PubMedCrossRefGoogle Scholar
  11. 11.
    Dowd JB, Smith JJ (1990) Balloon dilatation of the prostate. Urol Clin North Am 17:671–677PubMedGoogle Scholar
  12. 12.
    Fabricius PG, Weizert P, Dunzendorfer U et al. (1990) A randomized double-blind placebo controlled trial on the efficacy of once a day terazasin in benign prostatic hyperplasia. Prostate 3:85CrossRefGoogle Scholar
  13. 13.
    Franck O (1938) Die Sprengung des Prostataringes. Münch Med Wochenschr 85:777–782Google Scholar
  14. 14.
    Gill KP, Machan LS, Allison DJ, Williams G (1989) Bladder outflow tract obstruction from benign prostatic hypertrophy treated by balloon dilatation. Br J Urol 64:618–622PubMedCrossRefGoogle Scholar
  15. 15.
    Goldenberg SL, Perez-Marrero RA, Lee LM, Emerson L (1990) Endoscopic balloon dilatation of the prostate: early experience. J Urol 144:83–87PubMedGoogle Scholar
  16. 16.
    Hargreave TB, Stephenson TP (1977) Potency and prostatectomy. Br J Urol 49:683PubMedCrossRefGoogle Scholar
  17. 17.
    Harrison NW, DeSouza JV (1990) Prostatic stenting for outflow obstruction. Br J Urol 65:192PubMedCrossRefGoogle Scholar
  18. 18.
    Hinman F (ed) (1983) Benign prostatic hypertrophy. Springer, Berlin Heidelberg New York, Chap 5Google Scholar
  19. 19.
    Hollingsworth E (1910) Dilatation of the prostatic urethra for the relief of the symptoms of prostatic enlargement. Ann Surg 51:597–599Google Scholar
  20. 20.
    Holtgrewe HL, Valk WL (1964) Late results of transurethral prostatectomy. J Urol 92:51PubMedGoogle Scholar
  21. 21.
    Isorna S, Maynar M, Belon JL et al. (1989) Prostatic urethroplasty: endoscopic findings. Semin Intervent Radiol 6:46–56CrossRefGoogle Scholar
  22. 22.
    Iverson P, Bruskewitz K, Jensen ME, Madsen PO (1983) Transurethral prostatic resection in the treatment of prostatism with high urinary flow. J Urol 129:995–997Google Scholar
  23. 23.
    Johnson SD, Kuni CC, Castaneda F et al. (1987) MR imaging of patients undergoing prostatic balloon dilatation. Radiology 165:332Google Scholar
  24. 24.
    Kirby RS, Coppinger SWC, Corcoran M et al. (1987) Prazosin in the treatment of prostatic obstruction. Br J Urol 60:136PubMedCrossRefGoogle Scholar
  25. 25.
    Klein LA (1991) Balloon dilatation of the prostate as compared with transurethral resection of the prostate for treatment of benign prostatic hypertrophy. World J Urol 9:29–31CrossRefGoogle Scholar
  26. 26.
    Klein LA, Lemming B (1989) Balloon dilatation for prostatic obstruction. Urology 33:198–201PubMedCrossRefGoogle Scholar
  27. 27.
    Klein LA, Perez-Marrero RA, Bowers GW et al. (1990) Transurethral cystos-copic balloon dilatation of the prostate. J Endourol 4:183–191CrossRefGoogle Scholar
  28. 28.
    Lepor H, Sypherd D, Machi G, Denis J (1991) Randomized double-blind study comparing the effectiveness of balloon dilatation of the prostate and cystoscopy for the treatment of symptomatic benign prostatic hyperplasia. J Urol 145:362AGoogle Scholar
  29. 29.
    Libman E, Fichten CB (1987) Prostatectomy and sexual function. Urology 29:467PubMedCrossRefGoogle Scholar
  30. 30.
    Lindner A, Golomb J, Lev A (1987) Local hyperthermia of the prostate gland for the treatment of BPH and urinary retention. Br J Urol 60:567PubMedCrossRefGoogle Scholar
  31. 31.
    McLoughlin J, Gill KP, Abel PD, Williams G (1990) Symptoms versus flow rates versus urodynamics in the selection of patients for prostatectomy. Br J Urol 66:303–305PubMedCrossRefGoogle Scholar
  32. 32.
    McLoughlin J, Keane PF, Jager R et al. (1991) Dilatation of the prostatic urethra with a 35 mm balloon. Br J Urol 67:177–181PubMedCrossRefGoogle Scholar
  33. 33.
    Mebust WK, Holtgrewe HL, Cockett ATK et al. (1989) Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3885 patients. J Urol 141:243–247PubMedGoogle Scholar
  34. 34.
    Mebust WK, Holtgrewe HL (1989) Current status of transurethral prostatectomy: a review of the AUA National Cooperative Study. World J Urol 6:194–197CrossRefGoogle Scholar
  35. 35.
    Reddy PK, Wasserman N, Castaneda F, Castaneda-Zuniga WR (1988) Balloon dilatation of the prostate for treatment of benign prostatic hyperplasia. Urol Clin North Am 15:529–535PubMedGoogle Scholar
  36. 36.
    Roos NP, Wennberg JE, Malenka DJ et al. (1989) Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med 320:1120–1124PubMedCrossRefGoogle Scholar
  37. 37.
    Stoner E (1990) The clinical development of a 5-α-reductase inhibitor, finasteride. J Steroid Biochem 37:375CrossRefGoogle Scholar
  38. 38.
    Wasserman NF, Reddy PK, Zhang G et al. (1990) Experimental treatment of benign prostatic hyperplasia with transurethral balloon dilatation of the prostate: preliminary study in 73 humans. Radiology 177:485–494PubMedGoogle Scholar
  39. 39.
    Yerushalmi A, Fishelovitz Y, Singer D et al. (1985) Localized deep microwave hyperthermia in the treatment of poor operative risk patients with benign prostatic hyperplasia. J Urol 133:873PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • J. A. Vale
  • R. S. Kirby
    • 1
  1. 1.Department of UrologySt. Bartholomew’s HospitalWest Smithfield, LondonUK

Personalised recommendations